Status:

COMPLETED

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

Lead Sponsor:

St Vincent's Hospital, Sydney

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

HIV

Cardiovascular Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This is a research study into the effects of three drugs used to treat HIV infection. Some drugs used to treat HIV have been associated with changes in blood fats such as cholesterol that could be har...

Eligibility Criteria

Inclusion

  • Provision of signed, informed consent
  • Age \>18 years
  • HIV infection documented by HIV antibody test and Western Blot prior to study entry
  • No previous ART OR no ART for 6 months prior to randomisation
  • CD4+ count of \<500 cells/mm or viral load \>10,000 copies/ml within 60 days prior to randomisation
  • No genotypic resistance to Raltegravir, Tenofovir/emtricitabine, Darunavir, Ritonavir
  • Body mass index less than 30kg/m2

Exclusion

  • Primary HIV infection within the last 6 months
  • Active infection or opportunistic illness within the previous 30 days
  • Use of any medication contra-indicated with ritonavir-boosted darunavir or raltegravir
  • Use of lipid-lowering therapy
  • Diabetes mellitus (fasting glucose \>7.0mml/l or a prior diagnosis of diabetes)
  • Use of oral prednisolone \> 7.5mg daily or equivalent
  • pregnancy or Breast feeding
  • proven hypersensitivity to one or more components of the study meal

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2014

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT01258439

Start Date

November 1 2010

End Date

July 1 2014

Last Update

January 12 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Holdsworth House Medical Practice

Sydney, New South Wales, Australia, 2010

2

St Vincent Hospital, Clinical Research Program

Sydney, New South Wales, Australia, 2010